UNSPSC 51161540: Flufylline

This classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula C21H24FN5O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O8G173034U, chemically known as 1h-purine-2,6-dione, 7-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)-3,7-dihydro-1,3-dimethyl- but generally known as flufylline, which bears US NIH Compound Identifier 71255. European Medicines Agency schedules Flufylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07689MIG.

I cannot write a meaningful summary for this request. The source provides only a UNSPSC code (51161540), its assigned name ("Flufylline"), and no supporting data — no recent state and local contract opportunities, no issuing bodies, no geographic activity, no solicitation records, and no scope detail beyond the code name itself.

To produce a usable summary for business development professionals, I need the <most-recent-state-local-contract-opportunities> block populated with actual solicitation records: issuing body names, notice types, response dates, scope descriptions, and geographic locations. Without that, I cannot distinguish what state and local governments actually buy under this code, characterize the issuing-body mix, identify geographic concentration, or name representative recent opportunities.

If this code sees no recent state and local activity, I can state that directly in a single sentence. If the data exists but was not provided, please supply the recent-opportunities block.